ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0188

COVID-19 and Autoimmune Rheumatic Patients: Behavioral Changes Adopted by Patients in the Midst of the Pandemic

Dzifa Dey1, Bright Katso2, Saudatu Issaka2, Derrick Nyame3 and Patrick Adjei1, 1University of Ghana Medical School, Accra, Ghana, 2Rheumatology Unit Korle bu Teaching Hospital, Accra, Ghana, 3Korle bu Teaching Hospital, Accra, Ghana

Meeting: ACR Convergence 2022

Keywords: Access to care, COVID-19, health behaviors, Health Care, Minority Health

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Outcomes, Preferences, and Attitudes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Several changes following the COVID-19 pandemic have emerged globally regarding the delivery of healthcare services. Giving concerns that, patients with Autoimmune Rheumatic Disease (AIRD) may be at increased risk of severe COVID-19 disease, there is a significant need to look into behavioral changes (healthy or unhealthy) developed among this patient group in response to the global shift in healthcare delivery. This study sought to investigate the personal experiences of autoimmune rheumatic disease patients in Ghana following the outbreak.

Methods: We conducted a cross-sectional study among patients aged 18 years and above from the Autoimmune Rheumatic patient cohort at the Korle-Bu Teaching Hospital (KBTH) and those admitted at the hospital’s COVID-19 treatment center (from 1st August 2020 to 1st July 2021). We recruited participants via face-to-face visits to the KBTH rheumatology clinic, telephone and electronic surveys with the patients who did not report to clinic. Participants completed a structured questionnaire (both in print and electronic) on patient behavioral changes. We measured patients’ overall behavior change by observing specific changes in patients’ practices relating to their “prescription”, “service utilization” and “clinical advice”. Data on patient demographics and COVID-19 status were obtained using chart reviews

Results: We recruited 233 patients. Mean age and disease duration were 37 years and 77.6 months respectively. Majority of the participants 209 (89.7%) were females. The most common AIRD was SLE (54.5%). The majority 197 (84.5%) had good knowledge about COVID-19. Specific changes observed in patients’ practices are shown in table 1. About 65 (27.8%) patients made changes to the doses of their cs/bDMARDs and 55 (23.7%) to their steroids. Approximately 48 (20.6% ) patients reduced their Hydroxychloroquine dosage to conserve supply. Around 96.8% of total participants discontinued regular in-person hospital visits and adopted remote means of accessing care such as WhatsApp, telephone and video consultation either individually or in combination. 74 (31.8%) also reduced their regular visits to nurse-led, occupational therapy and physiotherapy clinics. Social distancing was adopted by 212 (91%) patients. Self-isolation and the use of personal protective equipment was adopted by 179 (77.1%) patients.

Conclusion: The outbreak of COVID-19 has resulted in various behavioral changes in AIRD patients as reported among our study cohort. Majority of these changes reflected in patient’s attitude towards seeking healthcare remotely and observing COVID-19 protocols as a means of protection. Despite the perceived risks, most did not make changes to their medication doses. This could inform practice and health care interventions in future such as telemedicine.

Supporting image 1

Table 1: Patient’s Knowledge of COVID_19 and Changes in patients’ Behaviour


Disclosures: D. Dey, Roche; B. Katso, None; S. Issaka, None; D. Nyame, None; P. Adjei, None.

To cite this abstract in AMA style:

Dey D, Katso B, Issaka S, Nyame D, Adjei P. COVID-19 and Autoimmune Rheumatic Patients: Behavioral Changes Adopted by Patients in the Midst of the Pandemic [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/covid-19-and-autoimmune-rheumatic-patients-behavioral-changes-adopted-by-patients-in-the-midst-of-the-pandemic/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/covid-19-and-autoimmune-rheumatic-patients-behavioral-changes-adopted-by-patients-in-the-midst-of-the-pandemic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology